Welcome
Support Centre
11 February 2012 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   press
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes

[ Print-friendly version ]
A randomised controlled placebo based trial to determine the efficacy of a prophylactic dose of hydrocortisone and anti histamine in preventing reactions to anti snake venom (ASV)
ISRCTN ISRCTN29425449
ClinicalTrials.gov identifier
Public title A randomised controlled placebo based trial to determine the efficacy of a prophylactic dose of hydrocortisone and anti histamine in preventing reactions to anti snake venom (ASV)
Scientific title
Acronym N/A
Serial number at source N/A
Study hypothesis A randomised controlled placebo based trial to determine the efficacy of a prophylactic dose of hydrocortisone and anti histamine in preventing reactions to anti snake venom
Lay summary
Ethics approval Not provided at time of registration
Study design Randomised controlled trial
Countries of recruitment India
Disease/condition/study domain Anaphylactoid and pryogenic reactions to anti snake venom
Participants - inclusion criteria 1. Snakebite with systemic symptoms
2. Requirment for ASV
3. Have given consent
Participants - exclusion criteria History of severe atopic diseases
Anticipated start date 01/10/2005
Anticipated end date 01/10/2008
Status of trial Completed
Patient information material
Target number of participants 250
Interventions Either a placebo or 100 mg of hydrocortisone and 10 mg of H1 anti histamine will be administered once reqirement for ASV has been established. All outcomes will be monitored. In the event of an adverse reaction normal treatment protocols will apply.
Primary outcome measure(s) Number of anaphyalactoid and pyrogenic reactions
Secondary outcome measure(s) Severity of reaction
Sources of funding St John's Medical College (India)
Trial website
Publications
Contact name Prof  Mabel  Vasnaik
  Address St John's Medical College
Johnagar
  City/town Bangalore
  Zip/Postcode 560034
  Country India
Sponsor St John's Medical College (India)
  Address Johnagar
  City/town Bangalore
  Zip/Postcode 560034
  Country India
Date applied 19/09/2005
Last edited 15/09/2009
Date ISRCTN assigned 29/09/2005
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2012 ISRCTN unless otherwise stated.


BioMed Central